Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 231

1.

Social functioning outcomes among individuals with substance use disorders receiving internet-delivered community reinforcement approach.

Marino LA, Campbell ANC, Pavlicova M, Hu M, Nunes EV.

Subst Use Misuse. 2019 Mar 8:1-8. doi: 10.1080/10826084.2018.1528458. [Epub ahead of print]

PMID:
30849925
2.

Responding to the Opioid Crisis: Lessons From a Review of Casualties.

Campbell ANC, Williams AR, Nunes EV.

Psychiatr Serv. 2019 Feb 1;70(2):89. doi: 10.1176/appi.ps.70202. No abstract available.

PMID:
30704376
3.

Development of a Cascade of Care for responding to the opioid epidemic.

Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M.

Am J Drug Alcohol Abuse. 2019;45(1):1-10. doi: 10.1080/00952990.2018.1546862. Epub 2019 Jan 24.

PMID:
30675818
4.

Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.

Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR.

Ann Intern Med. 2018 Dec 18. doi: 10.7326/M18-0227. [Epub ahead of print]

PMID:
30557443
5.

Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual.

Soares WE 3rd, Wilson D, Gordon MS, Lee JD, Nunes EV, O'Brien CP, Shroff M, Friedmann PD.

Drug Alcohol Depend. 2019 Jan 1;194:482-486. doi: 10.1016/j.drugalcdep.2018.10.035. Epub 2018 Dec 3.

PMID:
30522048
6.

Cost of pharmacotherapy for opioid use disorders following inpatient detoxification.

McCollister KE, Leff JA, Yang X, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR, Murphy SM.

Am J Manag Care. 2018 Nov;24(11):526-531.

7.

Modified cognitive behavioral therapy (M-CBT) for cocaine dependence: Development of treatment for cognitively impaired users and results from a Stage 1 trial.

Aharonovich E, Hasin DS, Nunes EV, Stohl M, Cannizzaro D, Sarvet A, Bolla K, Carroll KM, Genece KG.

Psychol Addict Behav. 2018 Nov;32(7):800-811. doi: 10.1037/adb0000398. Epub 2018 Oct 22.

PMID:
30346186
8.

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.

Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV.

Am J Psychiatry. 2019 Feb 1;176(2):129-137. doi: 10.1176/appi.ajp.2018.17070732. Epub 2018 Oct 19.

9.

Buprenorphine in the real world: coming to terms with misuse and diversion.

Nunes EV.

Am J Drug Alcohol Abuse. 2018;44(6):576-577. doi: 10.1080/00952990.2018.1504952. Epub 2018 Aug 17. No abstract available.

PMID:
30118320
10.

Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial.

Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF.

Am J Addict. 2018 Sep;27(6):465-470. doi: 10.1111/ajad.12784. Epub 2018 Aug 14.

PMID:
30106494
11.

Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.

Shulman M, Campbell A, Pavlicova M, Hu MC, Aharonovich E, Nunes EV.

Am J Addict. 2018 Sep;27(6):509-515. doi: 10.1111/ajad.12769. Epub 2018 Aug 9.

PMID:
30091814
12.

Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68].

Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.

J Subst Abuse Treat. 2018 Sep;92:99. doi: 10.1016/j.jsat.2018.06.015. Epub 2018 Jul 9. No abstract available.

PMID:
30032951
13.

Developing an opioid use disorder treatment cascade: A review of quality measures.

Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M.

J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2. Erratum in: J Subst Abuse Treat. 2018 Sep;92:99.

14.

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.

Lofwall MR, Walsh SL, Nunes EV, Bailey GL, Sigmon SC, Kampman KM, Frost M, Tiberg F, Linden M, Sheldon B, Oosman S, Peterson S, Chen M, Kim S.

JAMA Intern Med. 2018 Jun 1;178(6):764-773. doi: 10.1001/jamainternmed.2018.1052.

PMID:
29799968
15.

How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.

Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J.

Drug Alcohol Depend. 2018 Jul 1;188:135-140. doi: 10.1016/j.drugalcdep.2018.03.043. Epub 2018 May 1.

16.

Transcranial Magnetic Stimulation of Medial Prefrontal and Cingulate Cortices Reduces Cocaine Self-Administration: A Pilot Study.

Martinez D, Urban N, Grassetti A, Chang D, Hu MC, Zangen A, Levin FR, Foltin R, Nunes EV.

Front Psychiatry. 2018 Mar 16;9:80. doi: 10.3389/fpsyt.2018.00080. eCollection 2018.

17.

Assessment of the relationship between a written measure of empathy and an independently rated interview of Motivational Interviewing.

Smith JL, Bertone P, Carpenter KM, Wain RM, Hu MC, Amrhein PC, Nunes EV.

J Subst Abuse Treat. 2018 Apr;87:56-63. doi: 10.1016/j.jsat.2017.12.004. Epub 2017 Dec 13.

PMID:
29471927
18.

Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.

Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP.

J Empir Res Hum Res Ethics. 2018 Apr;13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20.

PMID:
29460668
19.

Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder.

Luo SX, Wall M, Covey L, Hu MC, Scodes JM, Levin FR, Nunes EV, Winhusen T.

Am J Drug Alcohol Abuse. 2018;44(6):653-659. doi: 10.1080/00952990.2017.1416474. Epub 2018 Jan 25.

20.

A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study.

Dakwar E, Nunes EV, Hart CL, Hu MC, Foltin RW, Levin FR.

Neuropharmacology. 2018 Nov;142:270-276. doi: 10.1016/j.neuropharm.2018.01.005. Epub 2018 Jan 5.

PMID:
29309770

Supplemental Content

Loading ...
Support Center